Insider trading

Period: 120 months Stock: SPRY + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

150 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

150 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

150 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

150 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
150 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
150 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

150 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
22 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$21.13K 2,343 at 9.02
0.1%
Planned (10b5-1)
21 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$4.25K 472 at 9.00
0.0%
Planned (10b5-1)
21 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$4.25K 472 at 9.00
0.0%
Planned (10b5-1)
19 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$17.32K 1,918 at 9.03
0.1%
Planned (10b5-1)
19 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$17.32K 1,918 at 9.03
0.1%
Planned (10b5-1)
15 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$884.49K 96,756 at 9.14
5.4%
Planned (10b5-1)
15 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$884.49K 96,756 at 9.14
5.4%
Planned (10b5-1)
14 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$4.00K 444 at 9.00
0.0%
Planned (10b5-1)
14 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$4.00K 444 at 9.00
0.0%
Planned (10b5-1)
13 Mar 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 2×
$25.20K 2,800 at 9.00
0.2%
Planned (10b5-1)
13 Mar 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 2×
$25.20K 2,800 at 9.00
0.2%
Planned (10b5-1)
29 Feb 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 3×
$34.10K 3,782 at 9.02
0.2%
Planned (10b5-1)
29 Feb 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 3×
$34.10K 3,782 at 9.02
0.2%
Planned (10b5-1)
28 Feb 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 3×
$891.06K 98,778 at 9.02
5.4%
Planned (10b5-1)
28 Feb 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 3×
$891.06K 98,778 at 9.02
5.4%
Planned (10b5-1)
26 Feb 2024
Tanimoto Sarina CHIEF MEDICAL OFFICER · indirect
Sold on a plan 3×
$6.31K 700 at 9.01
0.0%
Planned (10b5-1)
26 Feb 2024
Lowenthal Richard E PRESIDENT AND CEO · indirect
Sold on a plan 3×
$6.31K 700 at 9.01
0.0%
Planned (10b5-1)
29 Sep 2023
Fitzpatrick Alexander A Chief Legal Officer
Bought
$174.99K 46,258 at 3.78
108%
Largest buy in 3 yrs
28 Sep 2023
Fitzpatrick Alexander A Chief Legal Officer
Bought
$144.96K 40,000 at 3.62
×13
First buy on file
21 Sep 2023
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought 2×
$8.18M 2,700,000 at 3.03
46.1%
+46% of stake
1 Sep 2023
Shawver Laura Director
Sold on a plan
$770.52K 100,000 at 7.71
32.2%
Planned (10b5-1)
29 Aug 2023
RA CAPITAL MANAGEMENT, L.P. Director · indirect
Bought
$23.25M 3,750,000 at 6.20
178%
First buy on file
29 Aug 2023
ORBIMED ADVISORS LLC Director · indirect
Bought
$3.10M 500,000 at 6.20
6.6%
29 Aug 2023
Thompson Peter A. Director · indirect
Bought
$3.10M 500,000 at 6.20
6.6%
4 Aug 2023
Shawver Laura Director
Sold on a plan
$133.47K 18,897 at 7.06
8.2%
Planned (10b5-1)
3 Aug 2023
Shawver Laura Director
Sold on a plan
$183.02K 26,107 at 7.01
11.0%
Planned (10b5-1)
2 Aug 2023
Shawver Laura Director
Sold on a plan
$257.26K 36,281 at 7.09
14.7%
Planned (10b5-1)
1 Aug 2023
Shawver Laura Director
Sold on a plan
$134.58K 18,715 at 7.19
8.2%
Planned (10b5-1)
7 Jul 2023
Shawver Laura Director
Sold at will
$56.37K 8,858 at 6.36
4.0%
Not planned
6 Jul 2023
Shawver Laura Director
Sold at will
$212.55K 33,510 at 6.34
13.7%
Not planned
5 Jul 2023
Shawver Laura Director
Sold at will
$199.55K 31,112 at 6.41
12.9%
Not planned
3 Jul 2023
Shawver Laura Director
Sold at will
$178.35K 26,520 at 6.73
11.2%
Not planned
2 Jun 2023
Shawver Laura Director
Sold on a plan
$187.24K 26,941 at 6.95
11.4%
Planned (10b5-1)
1 Jun 2023
Shawver Laura Director
Sold on a plan
$496.80K 73,059 at 6.80
25.8%
Planned (10b5-1)
9 May 2023
Shawver Laura Director
Sold on a plan
$227.80K 42,900 at 5.31
16.9%
Planned (10b5-1)
8 May 2023
Shawver Laura Director
Sold on a plan
$351.74K 57,100 at 6.16
21.4%
Planned (10b5-1)
29 Nov 2022
Scott Kathleen D. Chief Financial Officer · indirect
Bought
$51.51K 8,250 at 6.24
opened
First buy on file
9 Nov 2022
Shawver Laura Director
Sold on a plan
$201.04K 43,896 at 4.58
17.3%
Planned (10b5-1)
15 Nov 2021
ROOT JONATHAN D Director · indirect
Bought
$17.82K 2,014 at 8.85
575%
+575% of stake
3 Mar 2021
ROOT JONATHAN D Director · indirect
Bought
$18.22K 350 at 52.07
opened
8 Dec 2020
Thompson Peter A. Director · indirect
Bought
$20.00M 952,377 at 21.00
opened
First buy on file
8 Dec 2020
ORBIMED ADVISORS LLC Director · indirect
Bought
$20.00M 952,377 at 21.00
opened
First buy on file
8 Dec 2020
Thompson Peter A. Director · indirect
Bought
$5.00M 238,100 at 21.00
88.4%
First buy on file
8 Dec 2020
ORBIMED ADVISORS LLC Director · indirect
Bought
$5.00M 238,100 at 21.00
88.4%
First buy on file
8 Dec 2020
Schroeder Thilo Director · indirect
Bought
$5.00M 238,096 at 21.00
opened
First buy on file
8 Dec 2020
ROOT JONATHAN D Director
Bought
$2.00M 95,238 at 21.00
opened
First buy on file
8 Dec 2020
Bought
$1,000.00K 47,619 at 21.00
opened
First buy on file
8 Dec 2020
Piazza Jonathan Chief Financial Officer
Bought
$249.98K 11,904 at 21.00
opened
First buy on file
8 Dec 2020
CAPPS VICKIE L Director
Bought
$199.98K 9,523 at 21.00
18.3%
First buy on file
8 Dec 2020
Hawkinson Russ Sr. Vice President of Finance
Bought
$5.00K 238 at 21.00
opened
First buy on file
Showing 101–150 of 150. ← Newer Page 3 of 3